Cargando…

Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study

BACKGROUND: This study assessed the utilization of biomedicine and Korean Medicine (KM) among hypertension patients. METHODS: The study was a cross-sectional analysis conducted using the Korean National Health and Nutrition Examination Survey (KNHANES), which is a nationwide survey conducted every y...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jang Won, Hyun, Min Kyung, Lee, Ji Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452361/
https://www.ncbi.nlm.nih.gov/pubmed/32904209
http://dx.doi.org/10.1016/j.imr.2020.100429
_version_ 1783575144823783424
author Lee, Jang Won
Hyun, Min Kyung
Lee, Ji Hyun
author_facet Lee, Jang Won
Hyun, Min Kyung
Lee, Ji Hyun
author_sort Lee, Jang Won
collection PubMed
description BACKGROUND: This study assessed the utilization of biomedicine and Korean Medicine (KM) among hypertension patients. METHODS: The study was a cross-sectional analysis conducted using the Korean National Health and Nutrition Examination Survey (KNHANES), which is a nationwide survey conducted every year for a representative Korean population. The use of outpatient healthcare services for hypertension patients was analyzed, and the usage determinants adjusted by the demographic and health status variables were identified. A chi-square test and logistic regression analysis were used for statistical analysis using R (version 3.6.0). RESULTS: Among 3320 hypertension patients, 208 patients (6.27%, Weighted%: 5.99%) used the biomedicine and KM concurrently. Multivariable regression analyses revealed hypertension patients who were obese (OR: 1.417, CI: 1.007–1.995) and had an experience of sickness (OR: 2.323, CI: 1.561–3.457) to be more likely to use biomedicine and KM concurrently. CONCLUSION: The utilization rate and determinants of the concurrent use of biomedicine and KM were identified in patients with hypertension. Although the overall usage rate was not high, the health care patterns of healthcare consumers need to be understood. Therefore, further studies on its effectiveness and safety are recommended.
format Online
Article
Text
id pubmed-7452361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74523612020-09-04 Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study Lee, Jang Won Hyun, Min Kyung Lee, Ji Hyun Integr Med Res Original Article BACKGROUND: This study assessed the utilization of biomedicine and Korean Medicine (KM) among hypertension patients. METHODS: The study was a cross-sectional analysis conducted using the Korean National Health and Nutrition Examination Survey (KNHANES), which is a nationwide survey conducted every year for a representative Korean population. The use of outpatient healthcare services for hypertension patients was analyzed, and the usage determinants adjusted by the demographic and health status variables were identified. A chi-square test and logistic regression analysis were used for statistical analysis using R (version 3.6.0). RESULTS: Among 3320 hypertension patients, 208 patients (6.27%, Weighted%: 5.99%) used the biomedicine and KM concurrently. Multivariable regression analyses revealed hypertension patients who were obese (OR: 1.417, CI: 1.007–1.995) and had an experience of sickness (OR: 2.323, CI: 1.561–3.457) to be more likely to use biomedicine and KM concurrently. CONCLUSION: The utilization rate and determinants of the concurrent use of biomedicine and KM were identified in patients with hypertension. Although the overall usage rate was not high, the health care patterns of healthcare consumers need to be understood. Therefore, further studies on its effectiveness and safety are recommended. Elsevier 2021-03 2020-05-23 /pmc/articles/PMC7452361/ /pubmed/32904209 http://dx.doi.org/10.1016/j.imr.2020.100429 Text en © 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Lee, Jang Won
Hyun, Min Kyung
Lee, Ji Hyun
Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title_full Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title_fullStr Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title_full_unstemmed Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title_short Determinants of concurrent use of Biomedicine and Korean Medicine on the hypertension patients: a cross-sectional study
title_sort determinants of concurrent use of biomedicine and korean medicine on the hypertension patients: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452361/
https://www.ncbi.nlm.nih.gov/pubmed/32904209
http://dx.doi.org/10.1016/j.imr.2020.100429
work_keys_str_mv AT leejangwon determinantsofconcurrentuseofbiomedicineandkoreanmedicineonthehypertensionpatientsacrosssectionalstudy
AT hyunminkyung determinantsofconcurrentuseofbiomedicineandkoreanmedicineonthehypertensionpatientsacrosssectionalstudy
AT leejihyun determinantsofconcurrentuseofbiomedicineandkoreanmedicineonthehypertensionpatientsacrosssectionalstudy